Hospira: In-house API production to reach 50% by 2018 through acquisitions
Hospira says it intends to up in-house manufacture of its APIs from 10 to 50% by 2018 as it awaits completion of last year’s acquisition of Orchid.
Archives for December 9, 2013
Brazil makes proposed outsourcing regulations available for comment
ANVISA has set out what it expects of contractors that provide manufacturing, quality control services and drug storage in the Federal Official Gazette of Brazil (DoU) and invited stakeholders to comment.
B Braun changes stoppers for medical baking soda after alert
B Braun Melsungen AG has changed the type of stoppers used to seal its injectable metabolic acidosis treatment, sodium bicarbonate, after quality problems that resulted in a UK MHRA alert last week.
Agilux doubles animal housing capacity
Preclinical CRO Agilux has increased capacity at its research facility in Massachusetts, US, citing customer desire for faster in vivo studies as the driver for the investment.